Clinical Trials on Under-vaccinated in New Zealand

Total 13 results

Eisai Co., Ltd.

Completed

A Pharmacokinetic (PK) Study of Three Types of E0302 Sustained Release (SR) Tablets Compared With E0302 Immediate Release (IR) Tablet Under Fed Conditions in Healthy Participants

Healthy Subjects

New Zealand
Hospital for Special Surgery, New York

Suspended

Effect of Colchicine on Range of Motion After Manipulation Under Anesthesia for the Stiff Total Knee Replacement (Colchine MUA)

Manipulation Under Anesthesia

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fed Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fed Conditions

Healthy

India
Future University in Egypt

Completed

Bioequivalence Study of Ribavirin in Healthy Adult Subjects Under Fed Condition

Healthy Subjects

Egypt
Austarpharma, LLC

Unknown

Bioequivalence Study of Oseltamivir Phosphate and TAMIFLU Under Fed Condition in Healthy Volunteers

Bioequivalence

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fed Conditions

Healthy

United States
Biotronik, Inc.

Completed

ProMRI Study of the Entovis Pacemaker System

Safety of the ProMRI Pacemaker System Under Specific MRI Conditions

United States
Bayer

Completed

A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufactuers Under Fed Conditions in Healthy Adult Subjects

Clinical Pharmacology

United States
Ranbaxy Laboratories Limited

Completed

A Relative Bioavailability Study of Acetaminophen 650 mg Extended Release Gelcaps Under Fed Condition

Healthy

India
Roxane Laboratories

Completed

Bioequivalency Study of Famciclovir 500 mg Tablets Under Fed Conditions

Herpes

United States
Behavior Therapy Associates, LLP

Completed

A Web Application to Reduce Heavy Drinking in First-time DWI Offenders

Heavy Drinking | Driving Under the Influence | Alcohol Abstinence | Driving While Intoxicated

United States
Roswell Park Cancer Institute
Celgene

Withdrawn

Enasidenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia With an IDH2 Gene Mutation

Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | IDH2 Gene Mutation | Blasts Under 5 Percent of Peripheral Blood White Cells | Bone Marrow Blasts Decreased by 50 Percent or More Compared to Pretreatment Level

United States

3

Subscribe